Core Cap Advisors, LLC Bridge Bio Pharma, Inc. Transaction History
Core Cap Advisors, LLC
- $2.64 Billion
- Q3 2025
A detailed history of Core Cap Advisors, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 1,000 shares of BBIO stock, worth $62,730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$62,730
Previous $43,000
18.6%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
419Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.16 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.03 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$832 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$781 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$582 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.3B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...